These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2277450)

  • 1. [Fundamental study on nuclear medicine imaging of cholinergic innervation in the brain: changes of neurotransmitter and receptor in animal model of Alzheimer's disease].
    Matsuda H; Kinuya K; Tsuji S; Terada H; Shiba K; Mori H; Sumiya H; Hisada K
    Kaku Igaku; 1990 Oct; 27(10):1099-107. PubMed ID: 2277450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).
    Marien MR; Parsons SM; Altar CA
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):876-80. PubMed ID: 3468515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat.
    Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
    Jope RS; Johnson GV
    Mol Pharmacol; 1986 Jan; 29(1):45-51. PubMed ID: 3945227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system.
    Rossner S; Schliebs R; Perez-Polo JR; Wiley RG; Bigl V
    J Neurosci Res; 1995 Jan; 40(1):31-43. PubMed ID: 7714924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA; Marien MR
    Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: search for an imaging index suitable for the early detection of Alzheimer's disease.
    Ogawa M; Iida Y; Nakagawa M; Kuge Y; Kawashima H; Tominaga A; Ueda M; Magata Y; Saji H
    Nucl Med Biol; 2006 Feb; 33(2):249-54. PubMed ID: 16546680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
    J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.
    Hernandez CM; Høifødt H; Terry AV
    J Psychiatry Neurosci; 2003 May; 28(3):197-209. PubMed ID: 12790160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
    Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
    Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic models of Alzheimer's disease.
    Patel S; Tariot PN
    Psychiatr Clin North Am; 1991 Jun; 14(2):287-308. PubMed ID: 2062722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 15. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?
    Mesulam M
    Learn Mem; 2004; 11(1):43-9. PubMed ID: 14747516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodinated (-)-2-[4-(3-iodophenyl) piperidino] cyclohexanol: a potential radioligand for mapping presynaptic cholinergic neurons.
    Shiba K; Mori H; Matsuda H; Ichikawa A; Tonami N
    Nucl Med Commun; 1996 Jun; 17(6):485-92. PubMed ID: 8822746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of radioiodinated (-)-m-iodovesamicol for diagnosing cholinergic deficit dementia.
    Shiba K; Mori H; Ikeda E; Sumiya H; Tonami N
    Nucl Med Biol; 2001 Apr; 28(3):261-4. PubMed ID: 11323235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.
    Gil-Bea FJ; García-Alloza M; Domínguez J; Marcos B; Ramírez MJ
    Neurosci Lett; 2005 Feb; 375(1):37-41. PubMed ID: 15664119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.
    Quirion R
    J Psychiatry Neurosci; 1993 Nov; 18(5):226-34. PubMed ID: 8297921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.
    Efange SM; Khare AB; Foulon C; Akella SK; Parsons SM
    J Med Chem; 1994 Aug; 37(16):2574-82. PubMed ID: 8057300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.